Turner syndrome and neurofibromatosis 1: Rare co-existence with important clinical implications
doi.org/10.15605/jafes.038.01.20
- Author:
Sunetra Mondal
1
;
Neha Agrawal
2
;
Subhankar Chowdhury
1
Author Information
1. Institute of Post Graduate Medical Education and Research (SSKM Hospital), Kolkata, India
2. Institute of Neuroscience, Kolkata, India
- Publication Type:Case Reports
- Keywords:
Neurofibromatosis-Noonan syndrome
- MeSH:
Turner syndrome;
Neurofibromatosis 1;
NF-1
- From:
Journal of the ASEAN Federation of Endocrine Societies
2023;38(1):114-119
- CountryPhilippines
- Language:English
-
Abstract:
A 16.5-year-old Indian female presented with secondary amenorrhoea, cubitus valgus, scoliosis and multiple lentigines on the face. Karyotyping revealed mosaic Turner syndrome (TS) with 45, X/46, X iXq. She also had multiple café-au-lait macules and axillary freckles but no neurofibroma and did not fulfil the classic criteria for diagnosis of Neurofibromatosis-1(NF1). Many of her macules were smaller than 15 mm in diameter, which might be due to her hypoestrogenic state. However, exome-sequencing found a pathologic variant consistent with NF1. She was started on daily oral estrogen, and oral progesterone for 10 days every month with close monitoring for neurofibroma and/or glioma expansion. Co-occurrence of NF1 and TS is extremely rare, TS and NF1 can both affect growth and puberty, cause different cutaneous and skeletal deformities, hypertension, vasculopathy and learning disabilities. Our case highlights the need for genetic testing in some cases with NF1 who do not strictly fulfil the NIH diagnostic criteria. We also emphasize the need for close monitoring during therapy with growth hormone, estrogen and progesterone due to the potential risk of tumour expansion in NF1.
- Full text:1329-Article Text-23129-1-10-20230517.pdf
